Amneal Pharmaceuticals, Inc. AMRX Payments Of Debt Extinguishment Costs
Payments Of Debt Extinguishment Costs at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfDebtExtinguishmentCosts.
The official record: Amneal Pharmaceuticals, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s payments of debt extinguishment costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s payments of debt extinguishment costs?
- Amneal Pharmaceuticals, Inc. (AMRX) reported payments of debt extinguishment costs of $18.74M in Q4 2025.
- How has Amneal Pharmaceuticals, Inc.'s payments of debt extinguishment costs changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s payments of debt extinguishment costs increased by 105495.8% year-over-year, from $17.75K to $18.74M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s payments of debt extinguishment costs?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s payments of debt extinguishment costs has grown at a 255.9% compound annual growth rate (CAGR), from $1.66M to $74.97M.
- What does payments of debt extinguishment costs mean?
- Represents the cash outflows associated with the early retirement or refinancing of debt obligations, including premiums paid to lenders and the write-off of unamortized issuance costs. High or frequent payments in this category may indicate active capital structure management or a strategic effort to reduce interest expense through debt restructuring.